DSpace Repository

Uterine metastasis from infiltrating ductal carcinoma of breast in a

Show simple item record

dc.contributor.author Meydanli, MM
dc.contributor.author Karadag, N
dc.contributor.author Ataoglu, O
dc.contributor.author Kafkasli, A
dc.date.accessioned 2022-03-07T11:46:06Z
dc.date.available 2022-03-07T11:46:06Z
dc.date.issued 2002
dc.identifier.uri http://hdl.handle.net/11616/54468
dc.description.abstract The established relationship between tamoxifen and the development of endometrial cancer causes differential diagnostic problems between metastatic and primary uterine neoplasms. A 45-year-old woman underwent modified radical mastectomy because of left-breast cancer. She presented with abnormal vaginal bleeding 6 years later, while still on tamoxifen therapy. The endometrial curettage revealed undifferentiated adenocarcinoma. She underwent total abdominal hysterectomy, bilateral salphingoopherectomy as well as pelvic and periaortic lymphadenectomy. Microscopic examination revealed neoplastic cells which formed sheets and duct-like structures in the endometrium. The pattern was not that of a primary endometrial tumour and an immunohistochemical staining was performed using human breast gross cystic disease fluid protein-15 (GCDFP-15) which was found out to be positive in the tumour cells. A diagnosis of metastatic ductal carcinoma of the breast in the uterus was rendered. Uterine metastasis should be kept in mind in patients with a history of breast cancer who are on tamoxifen therapy. (C) 2002 Elsevier Science Ltd. All rights reserved.
dc.source BREAST
dc.title Uterine metastasis from infiltrating ductal carcinoma of breast in a
dc.title patient receiving tamoxifen

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record